Abstract
Coordinated intracellular protein degradation mediated by the ubiquitin-proteasome pathway is crucial to a vast array of cellular processes including orderly progression through the mitotic cycle. Similarly important to both the fates of individual cells, as well as to the normal function of multicellular organisms, is the process of apoptosis, or programmed cell death. Execution of this latter process has been known for some time to be intimately associated with the activity of caspases, a family of proteases related to interleukin-1-β-converting enzyme. Evidence is now accumulating, however, that the ubiquitin-proteasome system itself plays an important role in apoptosis, and some of the cellular pathways that are impacted upon by the proteasome, and may lead to apoptosis, are beginning to be dissected. This review provides a summary of the experimental basis by which components of the ubiquitin-proteasome pathway have been linked to apoptosis, and attempts are made to formulate a hypothesis about its role in this process.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by J.C. Reed
Rights and permissions
About this article
Cite this article
Orlowski, R. The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 6, 303–313 (1999). https://doi.org/10.1038/sj.cdd.4400505
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400505
Keywords
This article is cited by
-
Rational design and development of novel NAE inhibitors for the treatment of pancreatic cancer
Medicinal Chemistry Research (2023)
-
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Acta Pharmacologica Sinica (2022)
-
Inhibition of noncaspase proteases, calpain and proteasome, via ALLN and Bortezomib contributes to cell death through low degradation of pro-/anti-apoptotic proteins and apoptosis induction
Medical Oncology (2022)
-
Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells
BMC Cancer (2021)
-
Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist
Cell Death & Disease (2021)